CSIMarket
 
Danaher Corporation  (NYSE: DHR)
    Sector • Technology    Industry • IT Infrastructure
   Industry • IT Infrastructure
   Sector • Technology
 

Danaher's Customers Performance

DHR



 
DHR's Source of Revenues Danaher's Corporate Customers have recorded an increase in their cost of revenue by 16.39 % in the 3 quarter 2026 year on year, sequentially costs of revenue grew by 21.01 %. During the corresponding time, Danaher Corporation recorded a revenue increase by 8.28 % year on year, sequentially revenue grew by 4.61 %. While revenue at the Danaher Corporation's corporate clients recorded rose by 15.75 % year on year, sequentially revenue grew by 9.23 %.

• List of DHR Customers




Danaher's Customers have recorded an increase in their cost of revenue by 16.39 % in the 3 quarter 2026 year on year, sequentially costs of revenue grew by 21.01 %, for the same period Danaher Corporation recorded revenue increase by 8.28 % year on year, sequentially revenue grew by 4.61 %.

• List of DHR Customers

Danaher's Business Units
Recurring revenue    84.54 % of total Revenue
Nonrecurring revenue    15.46 % of total Revenue
North America    41.64 % of total Revenue
Western Europe    26.3 % of total Revenue
Other developed markets    4.77 % of total Revenue
High-growth markets    27.29 % of total Revenue
segments    100 % of total Revenue
Biotechnology    30.2 % of total Revenue
Biotechnology Recurring revenue    27.59 % of total Revenue
Biotechnology Nonrecurring revenue    2.6 % of total Revenue
Biotechnology North America    8.81 % of total Revenue
Biotechnology Western Europe    12.2 % of total Revenue
Biotechnology Other developed markets    0.96 % of total Revenue
Biotechnology High-growth markets    8.23 % of total Revenue
Life Sciences    29.19 % of total Revenue
Life Sciences Recurring revenue    20.22 % of total Revenue
Life Sciences Nonrecurring revenue    8.97 % of total Revenue
Life Sciences North America    11.58 % of total Revenue
Life Sciences Western Europe    6.86 % of total Revenue
Life Sciences Other developed markets    2.37 % of total Revenue
Life Sciences High-growth markets    8.39 % of total Revenue
Diagnostics    40.62 % of total Revenue
Diagnostics Recurring revenue    36.73 % of total Revenue
Diagnostics Nonrecurring revenue    3.88 % of total Revenue
Diagnostics North America    21.26 % of total Revenue
Diagnostics Western Europe    7.24 % of total Revenue
Diagnostics Other developed markets    1.45 % of total Revenue
Diagnostics High-growth markets    10.67 % of total Revenue
Biotechnology segments    30.2 % of total Revenue
Life Sciences segments    29.19 % of total Revenue
Diagnostics segments    40.62 % of total Revenue




   
Customers Net Income grew in Q3 by Customers Net margin grew to
49.29 % 11.37 %
Customers Net Income grew in Q3 by 49.29 %


Customers Net margin grew to 11.37 %



Danaher's Customers, Q3 2026 Revenue Growth By Industry
Customers in Chemical Manufacturing Industry      4.91 %
Customers in Chemicals - Plastics & Rubber Industry -14.98 %   
Customers in Containers & Packaging Industry -1.97 %   
Customers in Forestry & Wood Products Industry      4.22 %
Customers in Miscellaneous Fabricated Products Industry      15.87 %
Customers in Aerospace & Defense Industry      6.99 %
Customers in Construction & Mining Machinery Industry      58.4 %
Customers in Construction Services Industry      31.62 %
Customers in Industrial Machinery and Components Industry      22.22 %
Customers in Ship & Boat Building Industry      12.45 %
Customers in Conglomerates Industry -52.02 %   
Customers in Appliance & Tool Industry -8.83 %   
Customers in Electronic Parts & Equipment Industry      20.39 %
Customers in EV, Auto & Truck Manufacturers Industry      0.23 %
Customers in Auto & Truck Parts Industry      1.84 %
Customers in Electric & Wiring Equipment Industry      16.02 %
Customers in Nonalcoholic Beverages Industry      6.22 %
Customers in Agricultural Production Industry      7.18 %
Customers in Food Processing Industry -1.98 %   
Customers in Personal & Household Products Industry      5.93 %
Customers in Oil & Gas Integrated Operations Industry      42.75 %
Customers in Consumer Financial Services Industry      3264.35 %
Customers in Real Estate Investment Trusts Industry -6.62 %   
Customers in Biotechnology & Pharmaceuticals Industry      7.77 %
Customers in Healthcare Facilities Industry      5.74 %
Customers in Major Pharmaceutical Preparations Industry      20.33 %
Customers in Medical Equipment & Supplies Industry      2.33 %
Customers in Medical Laboratories Industry      8.27 %
Customers in Broadcasting Media & Cable TV Industry -6.09 %   
Customers in Communications Services Industry      3.26 %
Customers in Communications Equipment Industry      32.6 %
Customers in IT Infrastructure Industry      63.26 %
Customers in Cloud Computing & Data Analytics Industry      1.78 %
Customers in Scientific & Technical Instruments Industry      28.86 %
Customers in Semiconductors Industry      7.04 %
Customers in Software & Programming Industry      20.22 %
Customers in Natural Gas Utilities Industry      43.15 %
Customers in Automotive Aftermarket Industry      5.64 %
     
• Customers Valuation • Customers Mgmt. Effect.


Danaher's Comment on Sales, Marketing and Customers



Danaher operates in approximately 50 countries, serving markets in science and technology. Its customer base includes unaffiliated customers primarily in North America, with 41% located in the United States, as well as in Canada, Eastern Europe, the Middle East, Africa, Latin America including Mexico, and Asia. The company targets science and technology markets and focuses on both recurring and nonrecurring revenue streams. Danaher pursues acquisitions and investments to complement or expand its portfolio in these markets and emphasizes continuous improvement and innovation.





Danaher’s Comment on Sales, Marketing and Customers


Danaher operates in approximately 50 countries, serving markets in science and technology. Its customer base includes unaffiliated customers primarily in North America, with 41% located in the United States, as well as in Canada, Eastern Europe, the Middle East, Africa, Latin America including Mexico, and Asia. The company targets science and technology markets and focuses on both recurring and nonrecurring revenue streams. Danaher pursues acquisitions and investments to complement or expand its portfolio in these markets and emphasizes continuous improvement and innovation.








DHR's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Danaher Corporation 159,977.11 25,608.00 4,331.00 60,000
Fulgent Genetics Inc 522.57 322.97 -85.47 1,344
Sophia Genetics Sa 447.11 77.08 -79.00 51
Veralto Corporation 28,589.72 5,801.00 1,002.00 17,000
Neogenomics Inc 2,120.40 788.12 -32.30 2,500
Fresenius Medical Care Ag 6,889.57 22,191.39 1,346.87 109,698
SUBTOTAL 34,049,878.83 12,348,233.59 1,180,277.16 15,781,904
283 more clients available

Sign in to see all corporate customers for Danaher Corporation.

Sources: Danaher Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Danaher Corporation’s corporate clients.
For your research, we’ve provided 9 tables on Danaher Corporation corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.